ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,513Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 403

$933K Total Retail Price of All Prescriptions

Rank: 8 out of 403

655 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 655 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 655 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 9,224 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 494 406 1 3
SIMVASTATIN 445 402 2 2
LISINOPRIL 340 295 3 1
FUROSEMIDE 328 237 4 7
HYDROCODONE-ACETAMINOPHEN 291 159 S3 5 15
ATORVASTATIN CALCIUM 286 261 6 5
OMEPRAZOLE 280 199 7 9
HYDROCHLOROTHIAZIDE 240 216 8 6
AMLODIPINE BESYLATE 224 220 9 4
METFORMIN HCL 218 185 10 8
METOPROLOL SUCCINATE 214 176 11 11
SERTRALINE HCL 198 130 12 20
ZOLPIDEM TARTRATE 184 115 13 16
METOPROLOL TARTRATE 179 155 14 10
WARFARIN SODIUM 156 120 15 12
ALENDRONATE SODIUM 155 126 16 26
GABAPENTIN 150 100 17 17
QUINAPRIL HCL 146 139 18 67
ATENOLOL 145 145 19 13
FLUOXETINE HCL 144 118 20 57
TRAZODONE HCL 126 87 21 25
TRAMADOL HCL 123 98 22 28
LOVASTATIN 119 112 23 42
NEXIUM 118 67 24 18
DIGOXIN 117 111 25 56
OXYCONTIN 113 68 S2 26 63
DIOVAN 108 90 27 24
OXYCODONE-ACETAMINOPHEN 107 83 S2 28 45
OXYCODONE HCL-ACETAMINOPHEN 107 22 S2 28 89
VENLAFAXINE HCL ER 104 69 30 95
CRESTOR 104 75 30 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 87 32 29
ADVAIR DISKUS 101 69 33 33
CITALOPRAM HBR 101 86 33 22
ESCITALOPRAM OXALATE 94 78 35 36
LOSARTAN POTASSIUM 90 80 36 21
LOSARTAN-HYDROCHLOROTHIAZIDE 86 74 37 91
POTASSIUM CHLORIDE 85 63 38 37
DONEPEZIL HCL 83 63 39 23
SPIRIVA 83 60 39 35
PREDNISONE 79 46 41 34
OXYCODONE HCL 78 39 S2 42 39
PANTOPRAZOLE SODIUM 73 71 43 30
GLIPIZIDE ER 72 68 44 86
CELEBREX 66 53 45 87
LANSOPRAZOLE 66 46 45 146
GLYBURIDE 65 31 R 47 88
DEXILANT 64 42 48 81
BUTALB-CAFF-ACETAMINOPH-CODEIN 62 62 S3 R 49 233
QUINAPRIL-HYDROCHLOROTHIAZIDE 62 62 49 233
LIPITOR 59 43 51 53
BUPROPION XL 57 41 52 159
DIOVAN HCT 56 56 53 69
HYDROMORPHONE HCL 56 0 S2 53 150
MELOXICAM 54 39 55 58
CYCLOBENZAPRINE HCL 52 31 R 56 91
JANUVIA 52 42 56 44
CIPROFLOXACIN HCL 51 40 58 130
DOXYCYCLINE HYCLATE 51 36 58 147
CLOTRIMAZOLE-BETAMETHASONE 51 46 58 173
MORPHINE SULFATE 50 0 S2 61 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.